Comparative studies of pharmacokinetics and anticoagulatory effect in rats after oral administration of Frankincense and its processed products

Journal of Ethnopharmacology

Volumn 172, Issue , 2015, Pages 118-123

  Pan, Ying Ni ^a   Liang, Xiao Xu ^a   Niu, Li Ying ^a   Wang, Yan Nian ^a   Tong, Xin ^a   Hua, Hui Ming ^a   Zheng, Jiang ^a,b   Meng, Dong Ya ^c   Liu, Xiao Qiu ^a  

^a SHENYANG PHARMACEUTICAL UNIVERSITY   (China)

^b UNIVERSITY OF WASHINGTON SCHOOL OF MEDICINE   (United States)

^c GENERAL HOSPITAL OF NORTHERN THEATER COMMAND   (China)

Author keywords

11 Keto boswellic acid (KBA); 3 Acetyl 11 keto boswellic acid (AKBA); Anticoagulatory effect; Frankincense; Pharmacokinetics; Processed Frankincense

Indexed keywords

11 OXO BETA BOSWELLIC ACID; 3 ACETYL 11 KETO BETA BOSWELLIC ACID; ANTICOAGULANT AGENT; D DIMER; FRANKINCENSE; PROSTACYCLIN; STIR FRIED FRANKINCENSE; THROMBIN ANTITHROMBIN COMPLEX; UNCLASSIFIED DRUG; VINEGAR PROCESSED FRANKINCENSE; 11-KETO-BOSWELLIC ACID; ACETYL-11-KETOBOSWELLIC ACID; ANTITHROMBIN III; ANTITHROMBIN III-PROTEASE COMPLEX; DAN-SHEN ROOT EXTRACT; FIBRIN DEGRADATION PRODUCT; FIBRIN FRAGMENT D; FIBRINOGEN; HERBACEOUS AGENT; PEPTIDE HYDROLASE; TRITERPENE;

ANIMAL EXPERIMENT; ANTICOAGULATION; AREA UNDER THE CURVE; ARTICLE; BLOOD CLOTTING; CONTROLLED STUDY; DRUG BLOOD LEVEL; DRUG CLEARANCE; DRUG DISTRIBUTION; DRUG HALF LIFE; HEMATOLOGY ANALYZER; HEMOSTASIS; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; LIMIT OF QUANTITATION; MALE; MAXIMUM PLASMA CONCENTRATION; MEAN RESIDENCE TIME; NONHUMAN; PARTIAL THROMBOPLASTIN TIME; PLASMA CLEARANCE; PROTHROMBIN TIME; RAT; THROMBIN TIME; TIME TO MAXIMUM PLASMA CONCENTRATION; VOLUME OF DISTRIBUTION; ANIMAL; BLOOD; COMPARATIVE STUDY; METABOLISM; ORAL DRUG ADMINISTRATION;

ANIMALIA; BOSWELLIA; BOSWELLIA SACRA; RATTUS; SALVIA MILTIORRHIZA;

ADMINISTRATION, ORAL; ANIMALS; ANTITHROMBIN III; DRUGS, CHINESE HERBAL; EPOPROSTENOL; FIBRIN FIBRINOGEN DEGRADATION PRODUCTS; FIBRINOGEN; FRANKINCENSE; MALE; PARTIAL THROMBOPLASTIN TIME; PEPTIDE HYDROLASES; PROTHROMBIN TIME; RATS; THROMBIN TIME; TRITERPENES;

EID: 84936752910     PISSN: 03788741     EISSN: 18727573     Source Type: Journal    
DOI: 10.1016/j.jep.2015.06.029     Document Type: Article

References (32)

1. T. Asaf, H. Reuveni, T. Yermiahu, A. Leiberman, G. Gurman, A. Porat, P. Schlaeffer, S. Shifra, and J. Kapelushnik The need for routine pre-operative coagulation screening tests (prothrombin time PT/partial thromboplastin time PTT) for healthy children undergoing elective tonsillectomy and/or adenoidectomy Int. J. Pediatric Otorhinolaryngol. 61 2001 217 222
2. N. Banno, T. Akihisa, K. Yasukawa, H. Tokuda, K. Tabata, Y. Nakamura, R. Nishimura, Y. Kimura, and T. Suzuki Anti-inflammatory activities of the triterpene acids from the resin of Boswellia carteri J. Ethnopharmacol. 107 2006 249 253
3. C. Benyahia, K. Boukais, I. Gomez, A. Silverstein, L. Clapp, A. Fabre, C. Danel, G. Leseche, D. Longrois, and X. Norel A comparative study of PGI2 mimetics used clinically on the vasorelaxation of human pulmonary arteries and veins, role of the DP-receptor Prostagland. Other Lipid Mediat. 107 2013 48 55
4. T. Eichhorn, H.J. Greten, and T. Efferth Molecular determinants of the response of tumor cells to boswellic acids Pharmaceuticals 4 2011 1171 1182
5. A. Fattahi, P. Petrini, F. Munarin, Y. Shokoohinia, M.A. Golozar, J. Varshosaz, and M.C. Tanzi Polysaccharides derived from tragacanth as biocompatible polymers and gels J. Appl. Polym. Sci. 129 2013 2092 2102
6. K. Gerbeth, J. Meins, S. Kirste, F. Momm, M. Schubert-Zsilavecz, and M. Abdel-Tawab Determination of major boswellic acids in plasma by high-pressure liquid chromatography/mass spectrometry J. Pharm. Biomed. Anal. 56 2011 998 1005
7. Gong, Q.-F., 2003. Science of Processing Chinese Materia Medica. In: N.u.o.C. (Ed.), Medicine, China Press of Traditional Chinese Medicine, Beijing.
8. H.-Z. Guan, and Z.-C. Peng Comparison between effect of the un-processed Ruxiangon rabbit's platelet adherence and that of the vinegar-processed one J. Hosp. Pharm. 20 2000 524 525
9. A. Gupta, A. Khajuria, J. Singh, S. Singh, K.A. Suri, and G.N. Qazi Immunological adjuvant effect of Boswellia serrata (BOS 2000) on specific antibody and cellular response to ovalbumin in mice Int. Immunopharmacol. 11 2011 968 975
10. J. Hüsch, J. Bohnet, G. Fricker, C. Skarke, C. Artaria, G. Appendino, M. Schubert-Zsilavecz, and M. Abdel-Tawab Enhanced absorption of boswellic acids by a lecithin delivery form (Phytosome®) of Boswellia extract Fitoterapia 84 2013 89 98
11. S.S. Hasson, M.S. Al-Balushi, T.A. Sallam, M.A. Idris, O. Habbal, and A.A. Al-Jabri In vitro antibacterial activity of three medicinal plants - Boswellia (Luban) species Asian Pac. J. Trop. Biomed. 2011 178 182
12. K. Itoh, Y. Tozuka, T. Oguchi, and K. Yamamoto Improvement of physicochemical properties of N-4472 part I formulation design by using self-microemulsifying system Int. J. Pharmaceutics 238 2002 153 160
13. A. Koeberle, U. Siemoneit, H. Northoff, B. Hofmann, G. Schneider, and O. Werz MK-886, an inhibitor of the 5-lipoxygenase-activating protein, inhibits cyclooxygenase-1 activity and suppresses platelet aggregation Eur. J. Pharmacol. 608 2009 84 90
14. P.K. Kokkiripati, L.M. Bhakshu, S. Marri, K. Padmasree, A.T. Row, A.S. Raghavendra, and S.D. Tetali Gum resin of Boswellia serrata inhibited human monocytic (THP-1) cell activation and platelet aggregation J. Ethnopharmacol. 137 2011 893 901
15. H.-X. Li, S.-Y. Han, X.-W. Wang, X. Ma, K. Zhang, L. Wang, Z.-Z. Ma, and P.-F. Tu Effect of the carthamins yellow from Carthamus tinctorius L. on hemorheological disorders of blood stasis in rats Food Chem. Toxicol. 47 2009 1797 1802
16. H.X. Li, S.Y. Han, X.W. Wang, X. Ma, K. Zhang, L. Wang, Z.Z. Ma, and P.F. Tu Effect of the carthamins yellow from Carthamus tinctorius L. on hemorheological disorders of blood stasis in rats Food Chem. Toxicol.: Int. J. Publ. Br. Ind. Biol. Res. Assoc. 47 2009 1797 1802
17. J.-L. Liu, and J.-N. Song TCM essence research work: blood stasis J. Liaoning Trad. Chin. Med. 33 2006 1091 1093
18. N. Mahfoudhi, M. Sessa, M. Chouaibi, G. Ferrari, F. Donsì, and S. Hamdi Assessment of emulsifying ability of almond gum in comparison with gum arabic using response surface methodology Food Hydrocolloids 37 2014 49 59
19. J.E. Mawdsley, M.G. Macey, R.M. Feakins, L. Langmead, and D.S. Rampton The effect of acute psychologic stress on systemic and rectal mucosal measures of inflammation in ulcerative colitis Gastroenterology 131 2006 410 419
20. R.A. Mothana Anti-inflammatory, antinociceptive and antioxidant activities of the endemic Soqotraen Boswellia elongata Balf. f. and Jatropha unicostata Balf. f. in different experimental models Food Chem. Toxicol.: Int. J. Publ. Br. Ind. Biol. Res. Assoc. 49 2011 2594 2599
21. Co.N. Pharmacopoeia Pharmacopoeia of People's Republic of China Co.N. Pharmacopoeia, Pharmacopoeia of People's Republic of China 2010 Chinese Medical Science and Technology Press Beijing 207
22. H. Safayhi, E.R. Sailer, and H.P.T. Ammon 5-Lipoxygenase inhibition by acetyl-11-keto-β-boswellic acid (AKBA) by a novel mechanism Phytomedicine 3 1996 71 72
23. H. Safayhi, B. Rall, E.-R. Sailer, and H.P.T. Ammon Inhibition by boswellic acids of human leukocyte elastase J. Pharmacol. Exp.Ther. 281 1997 460 463
24. M. Sartori, E. Favaretto, M. Cini, C. Legnani, G. Palareti, and B. Cosmi D-dimer, FVIII and thrombotic burden in the acute phase of deep vein thrombosis in relation to the risk of post-thrombotic syndrome Thromb. Res. 134 2014 320 325
25. Y.-L. Shen Frankincense processed products from different processing methods and hygiene products comparison of analgesic effect Guid. J. Tradit. Chin. Med. Pharm. 16 2010 118 119
26. U. Siemoneit, B. Hofmann, N. Kather, T. Lamkemeyer, J. Madlung, L. Franke, G. Schneider, J. Jauch, D. Poeckel, and O. Werz Identification and functional analysis of cyclooxygenase-1 as a molecular target of boswellic acids Biochem. Pharmacol. 75 2008 503 513
27. U. Siemoneit, A. Koeberle, A. Rossi, F. Dehm, M. Verhoff, S. Reckel, T.J. Maier, J. Jauch, H. Northoff, F. Bernhard, V. Doetsch, L. Sautebin, and O. Werz Inhibition of microsomal prostaglandin E2 synthase-1 as a molecular basis for the anti-inflammatory actions of boswellic acids from frankincense Br. J. Pharmacol. 162 2011 147 162
28. L. Sun, Liu Lina, Jin Hongyu, Tian Jingai, and Lin Ruichao Determination of Frankincense and processed Frankincense Chin. Pharm. Aff. 2010 972 974
29. L. Tausch, A. Henkel, U. Siemoneit, D. Poeckel, N. Kather, L. Franke, B. Hofmann, G. Schneider, C. Angioni, G. Geisslinger, C. Skarke, W. Holtmeier, T. Beckhaus, M. Karas, J. Jauch, and O. Werz Identification of human cathepsin G as a functional target of boswellic acids from the anti-inflammatory remedy frankincense J. Immunol. 183 2009 3433 3442
30. M.A. Tawab, A. Kaunzinger, U. Bahr, M. Karas, M. Wurglics, and M. Schubert-Zsilavecz Development of a high-performance liquid chromatographic method for the determination of 11-keto-β-boswellic acid in human plasma J. Chromatogr. B: Biomed. Sci. Appl. 761 2001 221 227
31. Z.-X. Tian Compare anti-inflammatory effects of Frankincense before and after processed and its mechanism J. Trad. Chin. Med. 26 2011 693 694
32. X. Tong, and X.-Q. Liu The TLC identification and content determination of Frankincense triterpene composition Mod. Chin. Med. 2012 11 14